HEMO2life® oxygen carrier medical device derived from Arenicola marina lugworm facilitating grafts preservation without delayed graft function opens up new
Morlaix (France), October 19, 2018 – EY has awarded the National Start-Up of the Year Prize to Hemarina and its
Morlaix and Boulogne-Billancourt (France), 29 November 2018 Hemarina and Delpharm today announced the signature of a partnership involving the manufacture
Morlaix, Brittany (France), March 23rd 2020 – Day 6 of confinement – Hemarina, a French biotech company, is ready to
Morlaix, Brittany (France), April 9th 2020 – Hemarina, the Breton biotech company, acknowledged the ANSM decision to suspend Monaco trial
Morlaix, Brittany (France) – Sept, 9, 2020 – Hemarina, a biotechnology company based in Brittany, announced today the publication of
Morlaix, Brest (France), 26 November 2020 – Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today
